Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Annals of the New York Academy of Sciences|October 4, 2007
Targeting vascular adhesion protein-1 to treat autoimmune and inflammatory diseasesDavid J Smith, Petri J VainioFood and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 7, 2016
Citizen scientist lepidopterists exposed to potential carcinogensPetri J Vainio, Tero Vahlberg, Jyrki LiesivuoriInternational Immunopharmacology|December 14, 2004
Novel sulfhydryl-reactive compounds orazipone and OR-1958 inhibit cytokine production and histamine release in rat and human mast cellsJohanna Vendelin, Charlotta Laitinen, Petri J Vainio, et al.Blood|January 17, 2004
Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1)Kaisa Koskinen, Petri J Vainio, David J Smith, et al.Basic & Clinical Pharmacology & Toxicology|May 25, 2005
Safety of blocking vascular adhesion protein-1 in patients with contact dermatitisPetri J Vainio, Outi Kortekangas-Savolainen, Jari H Mikkola, et al.Trials|January 12, 2021
Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trialPetri J Vainio, Pauliina Hietasalo, Anna-Liisa Koivisto, et al.Clinical Drug Investigation|October 5, 2011
Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre studyJørgen Matz, Claus Graff, Petri J Vainio, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 13, 2013
Preclinical evaluation of a radioiodinated fully human antibody for in vivo imaging of vascular adhesion protein-1-positive vasculature in inflammationAnu Autio, Petri J Vainio, Sami Suilamo, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 15, 2019
Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjectsJarkko Johansson, Jussi Hirvonen, Zsófia Lovró, et al.Pageof 1